News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mayr Charles M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/03/2014 |
4
| Mayr Charles M (Chief Communic Officer) has filed a Form 4 on Actavis plc|
Txns:
| Granted 10,087 options to buy
@ $0
Granted 9,180 options to buy
@ $224, valued at
$2.1M
|
|
| 05/13/2014 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc|
Txns:
| Granted 1,692 shares
@ $197.05, valued at
$333.4k
|
|
| 11/27/2013 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc|
Txns:
| Sold 10,000 shares
@ $162.6, valued at
$1.6M
|
|
| 10/03/2013 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc|
Txns:
| Granted 21,396 shares
@ $0 |
|
| 10/03/2013 |
3
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/14/2013 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.|
Txns:
| Sold 4,820 shares
@ $133.2295, valued at
$642.2k
|
|
| 03/14/2013 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.|
Txns:
| Sold 1,000 shares
@ $91.77, valued at
$91.8k
|
|
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2013 |
4
| Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 1,880 shares
@ $85.54, valued at
$160.8k
|
|
| 03/12/2012 |
4
| Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 5,199 shares
@ $0
Granted 4,276 shares
@ $0 |
|
| 02/28/2012 |
4
| Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 478 shares
@ $58.17, valued at
$27.8k
|
|
| 09/23/2011 |
4
| Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 632 shares
@ $70.04, valued at
$44.3k
|
|
| 02/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2009 |
4
| Mayr Charles M (Sr VP,Corp.Com & Inv.Relations) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
| 09/22/2009 |
3
| Mayr Charles M (Sr VP,Corp.Com & Inv.Relations) has filed a Form 3 on WATSON PHARMACEUTICALS INC |
|
|